posted on 2019-12-23, 18:20authored byKaren A Schlauch, Robert W. Read, Vincent C Lombardi, Gai Elhanan, William J Metcalf, Anthony D Slonim, 23andMe Research Team, Joseph J. Grzymski
Supplementary Figure S1: Quality-controlled average BMI values of participants.
Supplementary Figure S2: Manhattan plot of GWAS results of BMI with DM2-diagnosed individuals removed.
Supplementary Figure S3: ANOVA results for rs9939609.
Supplementary Table S1: GWAS results for BMI in a cohort with no DM2-diagnosed participants.
Supplementary Table S2: GWAS results for BMI in a cohort with DM2-diagnosed participants.
Supplementary Table S3: GWAS results the extreme obesity case-control study.
Supplementary Table S4: Significant EHR phenotypic associations with BMI.
Supplementary Table S5: Significant EHR phenotypic associations with extreme obesity.
Supplementary Table S6: Quality-controlled and averaged BMI participant values.
Supplementary Table S7: Counts of each phecode group.
History
Article title
A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in a Northern Nevadan Cohort